The new CMS pre-reimbursement review program being launched in 11 states next month will target unnecessary medical technology and devices in 15 procedures, according to a MassDevice report.
For the first three to nine months of the three-year test program, medical technology claims will be subject to a pre-payment review before requiring advance permission when the system is fully realized. This is a change from the standard procedure of identifying fraud after the payment has been made. Procedures on the list include spinal fusions, joint replacements and pacemaker and defibrillator surgeries.
Related Articles on Medical Devices:
Global Medical Device Market Will Reach $350B by 2016
Qualcomm Launches Medical Devices Subsidiary Backed by $100M Fund
Understanding EHR Opportunities for an ASC
For the first three to nine months of the three-year test program, medical technology claims will be subject to a pre-payment review before requiring advance permission when the system is fully realized. This is a change from the standard procedure of identifying fraud after the payment has been made. Procedures on the list include spinal fusions, joint replacements and pacemaker and defibrillator surgeries.
Related Articles on Medical Devices:
Global Medical Device Market Will Reach $350B by 2016
Qualcomm Launches Medical Devices Subsidiary Backed by $100M Fund
Understanding EHR Opportunities for an ASC